Visalytics
Visalytics
approved EB-2 (NIW)

Scientist

Chemistry And Biochemistry · Zimbabwe · 2025-03-06

Processing Time
297 days
Decision Date
2025-03-06
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop safe and effective gene therapies and delivery systems to improve treatment options for rare and complex disorders. Her work specifically focuses on uncovering how protofibrils contribute to neuronal damage in Alzheimer’s disease to support the development of targeted drug therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's work in gene therapy and Alzheimer's disease research was recognized for its potential to improve treatment options for complex disorders.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 203 citations and funding from agencies like the NIH and NSF demonstrated her capability to drive further advancements.

3 Balance of Interests Met

Given the petitioner's specialized expertise and the significance of her contributions to biomedical science, it was found beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's authorship of six peer-reviewed journal articles and 203 citations, demonstrating significant impact. Her research was supported by major funding from the NIH, NIA, and NSF, and she provided expert recommendation letters confirming her critical role in Alzheimer's research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Government Alignment

Similar Cases

Doctor

Healthcare · Israel

WeGreened EB-2 (NIW) approved
Ohio 56 days 2024-12-17
The petitioner proposes to advance the understanding of complex genetic disorders through the development of innovative genetic engineering models and tailored drug design methodologies. This work specifically focuses on investigating somatic mutations in the brains of individuals with Alzheimer’s disease to identify new pathways for diagnosis and therapeutic intervention. The endeavor aims to support the medical community in treating neurodegenerative processes and syndromic autism.
View Case

Researcher

Research and Development · Nepal

WeGreened EB-2 (NIW) rfe approved
Missouri 327 days 2022-10-06
The petitioner proposes to continue her research on analyzing the genetic networks underlying Alzheimer’s disease. Her work focuses on developing early diagnostic procedures and effective treatments for neurodegenerative diseases.
View Case

Postdoctoral Researcher

Research and Development · China

WeGreened EB-2 (NIW) approved
New Jersey 97 days 2022-06-16
The petitioner proposes to continue her research in molecular biology, specifically focusing on the molecular origins of neurological disorders such as Alzheimer’s and Parkinson’s disease. Her work involves studying progressive neurodegeneration to improve treatments for patients with these conditions and advancing the brain's ability to transmit information across various systems.
View Case

Scientist

Research and Development · India

WeGreened EB-2 (NIW) approved
Alabama 6 days 2024-03-07
The petitioner proposes to continue research using mouse model systems, high-resolution imaging, and molecular biology techniques to discover the mechanisms and molecular pathology of Parkinson’s disease. The work focuses on identifying effective therapeutic targets to improve patient quality of life and alleviate the economic burden associated with the condition.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Zimbabwe

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-06.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 297 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Zimbabwe All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist